[1]
Camara, B., Bognini, J.D., Nakakana, U.N., Some, A.M., Jagne, I., Tahita, M.C., Beloum, N., Sillah, F., Danso, M., Jones, J.C., Graves, S., Getanda, P., Rouamba, T., Ndure, E., Franck, H.S., Edmond, S.Y., Njie, Y., Dondeh, B.L., Wilfried, N.G.J., Bojang, A., Zakaria, G., Bottomley, C., D’Alessandro, U., Tinto, H. and Roca, A. 2022. Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase iii double-blind randomized clinical trial (PregnAnZI-2 trial). International Journal of Clinical Trials. 9, 1 (Jan. 2022), 34–44. DOI:https://doi.org/10.18203/2349-3259.ijct20220110.